6-145735227-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1PM5BP4_Moderate
The NM_005670.4(EPM2A):c.272G>A(p.Arg91Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000846 in 1,537,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R91P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_005670.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151702Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000549 AC: 9AN: 163796 AF XY: 0.0000669 show subpopulations
GnomAD4 exome AF: 0.00000866 AC: 12AN: 1385794Hom.: 0 Cov.: 30 AF XY: 0.0000102 AC XY: 7AN XY: 685906 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151702Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74096 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Progressive myoclonic epilepsy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 91 of the EPM2A protein (p.Arg91Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with EPM2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 580227). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on EPM2A protein function. This variant disrupts the p.Arg91 amino acid residue in EPM2A. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at